Genetic screening in new onset inflammatory bowel disease during anti-interleukin 17 therapy: unmet needs and call for action

Pages: 1 - 4
Published: Aug 30, 2021
Abstract
New onset inflammatory bowel disease (IBD) during anti-interleukin (IL)-17 therapy represents a rare but potentially dramatic adverse event (AE). A recent systematic review with meta-analysis by...
Paper Details
Title
Genetic screening in new onset inflammatory bowel disease during anti-interleukin 17 therapy: unmet needs and call for action
Published Date
Aug 30, 2021
Pages
1 - 4
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.